Kim Rivers has done what some thought was the impossible. With her role as Trulieve Cannabis Corp. CEO, head of a billion dollar medical marijuana empire and a direct line to President Donald Trump, she's been described as the "cannabis industry's Trump whisperer," in an April 17 article in Forbes Magazine.
Now the U.S. Department of Justice has lifted restrictions on medical marijuana products and reclassified them as a less dangerous drug, lumping them in with ketamine, steroids and Tylenol with codeine as a Schedule III drug instead of its previous Schedule I designation, where LSD and heroin are classified.
"Of all the CEOs running companies in the $30 billion (2025 sales) cannabis industry, Rivers has become the Trump whisperer," the article said.
"Many other executives have long boasted about their proximity to the president, or their lobbying efforts, but it was Rivers who successfully represented the industry and debated nay-sayers — including Speaker of the House Mike Johnson — in the Oval Office about why it's time for America to end its war on pot, start regulating it and studying its medical uses."
Read more at Tallahassee Democrat
